Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nucleic Acids Research|February 15, 2013
TriageTools: tools for partitioning and prioritizing analysis of high-throughput sequencing dataDanai Fimereli, Vincent Detours, Tomasz Konopka
BMC Cancer|April 18, 2015
No significant viral transcription detected in whole breast cancer transcriptomesDanai Fimereli, David Gacquer, Debora Fumagalli, et al.
Cancers|July 2, 2021
HER2-Low Breast Cancer: Molecular Characteristics and PrognosisElisa Agostinetto, Mattia Rediti, Danai Fimereli, et al.
Genes, Chromosomes & Cancer|February 14, 2018
Genomic hotspots but few recurrent fusion genes in breast cancerDanai Fimereli, Debora Fumagalli, David Brown, et al.
Oncotarget|June 2, 2016
miRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancersManuel Saiselet, Jaime M Pita, Alice Augenlicht, et al.
Endocrine-Related Cancer|February 19, 2015
Intratumor heterogeneity and clonal evolution in an aggressive papillary thyroid cancer and matched metastasesSoazig Le Pennec, Tomasz Konopka, David Gacquer, et al.
Cancers|December 23, 2023
Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal CancerIrene Assaf, Danai Fimereli, Geraldine Anthoine, et al.
Ebiomedicine|June 9, 2020
Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcomeDavid Venet, Danai Fimereli, Françoise Rothé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2024
Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical TrialMattia Rediti, Danai Fimereli, Magdalena Mileva, et al.
Ebiomedicine|July 26, 2022
Timing evolution of lobular breast cancer through phylogenetic analysisDanai Fimereli, David Venet, Mattia Rediti, et al.
Pageof 2